Add BrightSurf on Google Email

New risk score predicts mortality for atrial fibrillation patients undergoing transcatheter aortic valve replacement

A new risk score can help predict mortality for patients with atrial fibrillation who have undergone successful TAVR and been discharged home. The risk score was developed using data from the ENVISAGE-TAVI AF trial, which found that patients with certain clinical risks were more likely to die within a year of discharge.

“Polypill” reduces cardiovascular mortality by 33% in patients treated after a heart attack

The SECURE trial found that the polypill, containing aspirin, ramipril, and atorvastatin, achieves clinically relevant reductions in recurrent cardiovascular events among patients recovering from a heart attack. This simplified approach improves treatment adherence, leading to a 33% reduction in cardiovascular mortality.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 26, 2022

Cardiac arrest survival rate rising

The study found that the probability of surviving cardiac arrest outside hospital has more than doubled in 30 years, from approximately 5% to 11%. The improvement is attributed to increased CPR training and better healthcare resources. However, ambulance delays and an increase in difficult-to-treat cases are hindering further progress.

SourceUniversity of Gothenburg·JournalEuropean Heart Journal·TypeData/statistical analysis·DateAug 26, 2022

Dentists should give antibiotics to high-risk patients to help prevent life-threatening heart infection

A new study from the University of Sheffield suggests that giving antibiotics to those at high risk of developing a life-threatening heart infection significantly reduces their risk. Current UK guidelines against routine use of antibiotics for these patients may be putting them at unnecessary extra risk.

SourceUniversity of Sheffield·JournalJournal of the American College of Cardiology·TypeObservational study·DateAug 18, 2022

RCSI study provides insight into why babies with Down Syndrome experience heart and lung problems

A RCSI study has found that babies born with Down Syndrome experience impaired changes in heart function and blood pressure in their lungs over the first two years of age. The research suggests that all babies with Down Syndrome should have their heart function monitored during childhood due to these common issues.

SourceRCSI·JournalJournal of the American Society of Echocardiography·DateAug 16, 2022

The AABB releases clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma

The AABB has released clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma, recommending its use for nonhospitalized patients at high risk for disease progression. The guidelines suggest that CCP is most effective when transfused with high neutralizing titers early after symptom onset.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeSystematic review·DateAug 15, 2022

JACC study makes case for expanding coverage for carotid artery stenting

A new study published in the Journal of the American College of Cardiology suggests that carotid artery stenting can be just as effective as surgery in preventing long-term stroke and improving durability. The research recommends expanding insurance coverage for this minimally invasive procedure, which can improve blood flow to the brain.

SourceOchsner Health System·JournalJournal of the American College of Cardiology·DateAug 3, 2022

“One change a day makes 365 changes in a year”

A study published in the European Heart Journal found that making small behavioral changes can significantly reduce cardiovascular risk. Participants who received a lifestyle intervention showed improvements in physical activity, diet, and sedentary time, leading to decreased blood pressure and cholesterol levels.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEuropean Heart Journal·TypeRandomized controlled/clinical trial·DateJul 26, 2022

New heart model to help treat patients with heart failure

Researchers at RCSI University have created a new lab-based model to test devices for heart failure with preserved ejection fraction. The model enables testing of the left atrium and ventricle, two independently controlled chambers that simulate blood flow during the resting phase.

SourceRCSI·JournalFrontiers in Cardiovascular Medicine·DateJul 26, 2022

Spanish scientists combine genetic and imaging data to improve the treatment of dilated cardiomyopathy

A Spanish study combines genetic and imaging data to predict patient prognosis, identifying those at risk of malignant arrhythmias or severe complications. The findings open the way for personalized medicine in treating dilated cardiomyopathy.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEuropean Journal of Heart Failure·TypeRandomized controlled/clinical trial·DateJul 26, 2022

A healthy lifestyle can offset a high genetic risk for stroke, according to new research by UTHealth Houston

A new study published in the Journal of the American Heart Association found that people with high genetic risk for stroke can reduce their risk by 30-45% by adopting a healthy cardiovascular lifestyle. The study followed 11,568 adults over 28 years and showed that modifying lifestyle risk factors can offset genetic risk.

SourceUniversity of Texas Health Science Center at Houston·JournalJournal of the American Heart Association·DateJul 20, 2022

Ochsner study shows that social circumstances have outsized impact on hypertension control

A large clinical trial conducted at Ochsner Health found that social determinants of health, including financial stress and lack of health literacy, have a significant impact on blood pressure control rates among patients with uncontrolled hypertension. The study suggests that these barriers can eliminate racial disparities in hyperten...

SourceOchsner Health System·JournalMayo Clinic Proceedings·DateJul 20, 2022

High blood viscosity can predict higher risk of death in hospitalized COVID-19 patients

Hospitalized COVID-19 patients with high blood viscosity have a 60% higher death rate than those with low blood viscosity. The study suggests that checking for blood viscosity early on could help determine the best treatment course and improve outcomes.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·TypeObservational study·DateJul 18, 2022

Stress testing can help determine which patients are likely to benefit from heart procedures to improve survival

The study found that patients with severe stress-induced myocardial ischemia are likely to benefit from heart bypass surgery or angioplasty, while those with mild or no ischemia are not. Early revascularization was associated with a more than 30 percent reduction in mortality compared to patients treated with medication.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·TypeData/statistical analysis·DateJul 11, 2022

Specific environmental exposures may help predict increased risk of death from cardiovascular disease

A new study found that exposure to air pollution and indoor burning without ventilation significantly increases the risk of heart disease mortality. Researchers created maps of eight environmental risk factors across Golestan Province, Iran, and identified associations between death and these factors, controlling for traditional risk f...

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalPLOS ONE·TypeData/statistical analysis·DateJun 24, 2022

Up to 80% of athletes who die suddenly had no symptoms or family history of heart disease

The European Society of Cardiology recommends genetic testing for athletes with certain genetic mutations to prevent sudden cardiac death. Athletes with conditions like hypertrophic cardiomyopathy and long QT syndrome may need to limit their exercise intensity or take preventive measures such as wearing a defibrillator.

SourceEuropean Society of Cardiology·JournalEuropean Journal of Preventive Cardiology·DateJun 16, 2022

Spinal anesthesia associated with more pain, prescription analgesic use after hip surgery compared with general anesthesia

A randomized controlled trial found that spinal anesthesia was associated with worse pain immediately after surgery, but differences diminished over time. Researchers also found higher rates of pain reliever prescriptions at 60 days in the spinal anesthesia group.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateJun 13, 2022

Heart failure patients unvaccinated against COVID-19 are three times more likely to die from it than boosted heart failure patients

A new study from Mount Sinai Heart found that heart failure patients unvaccinated against COVID-19 are three times more likely to die from it than those who are fully vaccinated and boosted. The research also shows that these unvaccinated patients face higher risks of hospitalization and ICU admission if infected with the virus.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Cardiac Failure·TypeObservational study·DateJun 9, 2022

COVID-19's toll on global cardiac services - UK Version

A major international study reveals the significant impact of COVID-19 on cardiovascular services worldwide, with a substantial decline in hospital admissions and increased mortality rates. The study warns that problems with heart health will continue to accrue unless mitigation strategies are implemented quickly.

SourceUniversity of Leeds·JournalEuropean Heart Journal·TypeSystematic review·DateMay 30, 2022

New study from IU researchers finds strong association between the race of fellowship directors and the racial demographics of their programs

A recent study published in JACC: Advances has discovered a significant correlation between the racial demographics of cardiovascular disease fellowship programs and the race of their program directors. The study, led by Indiana University researcher Ankur Kalra, found that fellows from diverse backgrounds are more likely to be accepte...

SourceIndiana University School of Medicine·JournalJournal of the American College of Cardiology·DateMay 24, 2022

NACMI: International COVID-19 registry finds significant increased risk of in-hospital mortality for STEMI patients with COVID-19 compared to pre-pandemic

A new analysis from the NACMI registry found that STEMI patients with COVID-19 have a significant increased risk of in-hospital mortality compared to pre-pandemic levels. Clinical characteristics and treatment strategies differ between men and women, highlighting the need for continued research into cardiovascular health impacts of COV...

Disrupt PAD III trial demonstrates safety and effectiveness of intravascular lithotripsy for peripheral artery calcification

The Disrupt PAD III trial found intravascular lithotripsy (IVL) to be effective in treating severely calcified peripheral artery lesions, with high patency rates compared to percutaneous transluminal angioplasty (PTA). IVL also showed reduced severe complications and need for additional interventions.

SCAI issues official guidelines for the management of patent foramen ovale

The Society for Cardiovascular Angiography & Interventions has released official guidelines for the management of patent foramen ovale (PFO), addressing five clinical scenarios. The guidelines provide a comprehensive framework for PFO closure in various situations, aligning with stroke neurology principles.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateMay 19, 2022

First intermediate to long-term study of the harmony transcatheter pulmonary valve system validates safety and efficacy

A one-year study validated the Harmony transcatheter pulmonary valve (TPV) system's safety and efficacy in treating congenital heart disease patients with severe pulmonary regurgitation. The study showed favorable clinical and hemodynamic outcomes, including low mortality rates and minimal interventions.

Nationwide study finds significant decline in treatment for heart attacks during pandemic

A nationwide study analyzing rates of percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) found a nearly 30% decline following the COVID-19 pandemic. STEMI cases have yet to recover to pre-pandemic levels, suggesting continued hesitation among patients to seek hospital care despite having a heart att...